Diego Rosselli1, Camila Quirland-Lazo2, Marcell Csanádi3, Eva María Ruiz de Castilla4, Nelly Cisneros González5, Julio Valdés6, Cesar Abicalaffe7, William Garzón8, Giovanny Leon9, Zoltán Kaló10. 1. Medical School, Pontificia Universidad Javeriana, Bogota, Colombia. 2. Escuela de Salud Pública, Universidad de Chile, Santiago, Chile. 3. Syreon Research Institute, Budapest, Hungary. 4. Esperantra, Asociacion de ayuda al paciente con Cáncer, Lima, Peru. 5. Mexican Institute of Social Security, Mexico City, Mexico. 6. Consejo de Ministros de Salud de Centroamérica y República Dominicana (COMISCA), Antiguo Cuscatlán, El Salvador. 7. 2IM Inteligencia Medica, Curitiba, Brazil. 8. Asamblea Nacional del Ecuador, Quito, Ecuador. 9. Novartis Pharma AG, Basel, Switzerland. 10. Syreon Research Institute, Budapest, Hungary; Faculty of Social Sciences, Department of Health Policy and Health Economics, Institute of Economics, Eötvös Loránd University, Budapest, Hungary. Electronic address: zoltan.kalo@syreon.eu.
Abstract
OBJECTIVES: To provide an overview about the current status of health technology assessment (HTA) implementation in Latin American countries and to identify long-term objectives considering regional commonalities. METHODS: We conducted a survey among participants of the 5th Latin American Future Trends Conference in October 2015. Thirty-seven respondents from eight Latin American countries provided insights about the current and preferred future status of HTA implementation related to human capacity building, HTA financing, process and organizational structure for HTA, scope of mandatory HTA, decision criteria, standardization of HTA methodology, mandating the use of local data, and international collaboration in HTA. RESULTS: Survey respondents reported insufficient human resources and public investment for HTA implementation. Organizational structure and legislation framework of HTA differ considerably across countries. According to survey respondents, in the future policymakers should rely more on the assessment of therapeutic value, cost-effectiveness, and budget impact criteria by applying explicit thresholds, potentially in a multicriteria decision analysis framework. HTA should not be restricted to policy decisions of new technologies but it should also be used for the revision of previous decisions. In addition, the quality and transparency of HTA have to be strengthened. CONCLUSIONS: HTA plays an increasingly important role in Latin American countries. Each country needs to record its current implementation status and identify components for improvement. Duplication of efforts can be reduced if international collaboration is integrated into national HTA implementation.
OBJECTIVES: To provide an overview about the current status of health technology assessment (HTA) implementation in Latin American countries and to identify long-term objectives considering regional commonalities. METHODS: We conducted a survey among participants of the 5th Latin American Future Trends Conference in October 2015. Thirty-seven respondents from eight Latin American countries provided insights about the current and preferred future status of HTA implementation related to human capacity building, HTA financing, process and organizational structure for HTA, scope of mandatory HTA, decision criteria, standardization of HTA methodology, mandating the use of local data, and international collaboration in HTA. RESULTS: Survey respondents reported insufficient human resources and public investment for HTA implementation. Organizational structure and legislation framework of HTA differ considerably across countries. According to survey respondents, in the future policymakers should rely more on the assessment of therapeutic value, cost-effectiveness, and budget impact criteria by applying explicit thresholds, potentially in a multicriteria decision analysis framework. HTA should not be restricted to policy decisions of new technologies but it should also be used for the revision of previous decisions. In addition, the quality and transparency of HTA have to be strengthened. CONCLUSIONS: HTA plays an increasingly important role in Latin American countries. Each country needs to record its current implementation status and identify components for improvement. Duplication of efforts can be reduced if international collaboration is integrated into national HTA implementation.
Authors: Julia Bidonde; Jose Francisco Meneses-Echavez; Brian Asare; Lumbwe Chola; Mohamed Gad; Lieke Fleur Heupink; Elizabeth Fleur Peacocke Journal: BMC Med Res Methodol Date: 2022-03-22 Impact factor: 4.615
Authors: Julia Simões Corrêa Galendi; Carlos Antonio Caramori; Clarissa Lemmen; Dirk Müller; Stephanie Stock Journal: Int J Environ Res Public Health Date: 2021-11-13 Impact factor: 3.390